IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Iambic Therapeutics, Inc.
$16.34−7.47 (-31.37%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$7.47 (−31.37%)since Oct 16, 2026
Weekly closes, adjusted for splits, on a log scale. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –